CD52 and asthma: Since the precise mechanisms through which alemtuzumab exerts its therapeutic effects are still not entirely known, a better understanding of CD52’s biological functions will be needed in order to determine its role in the development of asthma, particularly with respect to other subtypes besides those induced by allergens.